Meeting
2019 ASCO Annual Meeting
Germline multigene panel testing in colorectal cancer: Precision therapy and clinical management implications.
Authors
Edward D. Esplin
Invitae, San Francisco, CA
Edward D. Esplin , Shan Yang , Scott T. Michalski , Daniel Esteban Pineda Alvarez , Stephen E Lincoln , Robert L. Nussbaum
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal (Colorectal) Cancer
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Epidemiology/Outcomes
Citation
J Clin Oncol 37, 2019 (suppl; abstr 3582)
DOI
10.1200/JCO.2019.37.15_suppl.3582
Abstract #
3582
Poster Bd #
74
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
A phase II study of olaparib (AZD2281) in patients (Pts) with metastatic/advanced urothelial carcinoma and other genitourinary (GU) tumors with DNA-repair defects.
First Author: Elias Chandran
Poster
2023 ASCO Annual Meeting
Spectrum of germline pathogenic variants among patients with cancer in Mexico.
First Author: Jose Luis Rodriguez Olivares
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Pathogenic variants among Mexican patients with colorectal cancer referred for genetic cancer risk assessment.
First Author: Jose Luis Rodriguez Olivares
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Germline pathogenic variants among Mexican patients with adenocarcinoma of the pancreas.
First Author: Jose Luis Rodriguez Olivares